Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Cancer arises due to genetic alterations that disrupt numerous cellular functions including proliferation, programmed cell death and senescence, that ultimately control the number of cells in a population. The genetic damage that underlies the development of cancers has a diverse etiology and loss of DNA repair mechanisms also may play a role in allowing mutations to accumulate. Cancers are also characterized by the ability to invade surrounding tissues and to metastasize. Many of the molecular alterations involved in this process have yet to be elucidated.
Gynecologic cancers afflict women of all ages. Cervical cancer is the most common gynecologic malignancy worldwide, accounting for over 400,000 cases annually. Endometrial cancer is the most common gynecologic malignancy with approximately 33,000 new cases being diagnosed annually in American women. Ovarian cancer is the fourth most common cause of cancer related mortality in American women, with approximately 14,000 deaths occurring from it in 2000.
The creation of a tissue repository containing tissue specimens, blood/serum, and molecular extracts (DNA, RNA, protein) will provide a rich source of tissue for future gynecological disease research studies.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Cynthia A Perry, CIP
- Phone Number: (202) 782-8461
- Email: cynthia.perry@amedd.army.mil
Study Contact Backup
- Name: Karen Livornese, RCN, BSN, CCRC
- Phone Number: (202) 782-6244
- Email: Karen.Livornese@amedd.army.mil
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Recruiting
- Washington Hospital Center
-
Contact:
- Velega E Roberts, RN, MS
- Phone Number: 202-877-8517
- Email: Velega.E.Roberts@medstar.net
-
Principal Investigator:
- Jonathon Cosin, MD
-
Washington, District of Columbia, United States, 20307
- Recruiting
- Gynecologic Disease Center, Walter Reed Army Medical Center
-
Principal Investigator:
- LTC G. Larry Maxwell, MD
-
Contact:
- Cynthia A Perry, MS
- Phone Number: (202) 782-8461
- Email: Cynthia.Perry@amedd.army.mil
-
Contact:
- Karen Livornese, RNC, BSN, CCRC
- Phone Number: (202) 782-6244
- Email: Karen.Livornese@amedd.army.mil
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Not yet recruiting
- Wayne State University Kamanos Cancer Institute
-
Contact:
- Alison Fried
- Phone Number: 313-576-9446
- Email: afried@med.wayne.edu
-
Principal Investigator:
- Robert T Morris, MD
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Recruiting
- Duke University Medical Center
-
Contact:
- Barbara Walukas, RN
- Phone Number: 919-684-6159
- Email: barbara.walukas@duke.edu
-
Principal Investigator:
- Andrew Berchuck, MD
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- The Ohio State University
-
Principal Investigator:
- Jeffrey Fowler, MD
-
Contact:
- Michele Vaughan
- Phone Number: 614-582-0280
- Email: vaughan-2@medctr.osu.edu
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15232
- Recruiting
- University of Pittsburgh Medical Center
-
Principal Investigator:
- Robert Edwards, MD
-
Contact:
- Tracy Davis, RN
- Phone Number: 412-641-1157
- Email: tdavis@mail.magee.edu
-
Windber, Pennsylvania, United States, 15963
- Not yet recruiting
- Windber Research Institute
-
Contact:
- Micheal Liebman, PhD
- Phone Number: 814-467-9844
-
Principal Investigator:
- Micheal Liebman, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients scheduled to undergo surgery for diagnosis and treatment of a gynecologic disease at one of the participating institutions
- > = 18 years old
- Ability to read English
Exclusion Criteria:
- < 18 years old
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: LTC G. Larry Maxwell, MD, Walter Reed Army Medical Center
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms, Connective and Soft Tissue
- Neoplasms by Histologic Type
- Urogenital Neoplasms
- Neoplasms by Site
- Uterine Neoplasms
- Genital Neoplasms, Female
- Uterine Cervical Diseases
- Uterine Diseases
- Endocrine System Diseases
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Endocrine Gland Neoplasms
- Connective Tissue Diseases
- Neoplasms, Connective Tissue
- Neoplasms, Muscle Tissue
- Neoplasms
- Uterine Cervical Neoplasms
- Ovarian Neoplasms
- Endometrial Neoplasms
- Leiomyoma
- Myofibroma
Other Study ID Numbers
Other Study ID Numbers
- 04-44017
- W81XWH-05-2-0005
- A-12818.1a
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.